A 6-week individualized smoking cessation program led to greater quit rates among patients with RA when compared with usual care.
TipRanks on MSN
Eli Lilly’s New Study on Brenipatide: A Potential Game-Changer in Smoking Cessation
Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and Company is ...
Adult patients with severe CRSwNP treated with tezepelumab continued to receive benefit 24 weeks after treatment cessation.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback